Recurrent Non-small Cell Lung Cancer (NSCLC)
1 clinical trials · Condition
◉ Watch Recurrent Non-small Cell Lung Cancer (NSCLC)
| Record | Firm | Date |
|---|---|---|
| Phase 2 Etirinotecan Pegol in Refractory Brain Metastases & Advanced Lung Cancer / Metastatic Breast Cancer (NCT02312622) | Joel Neal | 2015-08-01 |
Track Recurrent Non-small Cell Lung Cancer (NSCLC) automatically
Every clearance here is in the API, with alerts when new ones post.